BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 20217631)

  • 41. [Mechanisms of control in bone formation and resorption].
    Suda T
    Ryumachi; 1988 Dec; 28(6):409-13. PubMed ID: 3249975
    [No Abstract]   [Full Text] [Related]  

  • 42. Bone modelling in the implantation bed.
    Boyde A; Jones SJ
    J Biomed Mater Res; 1985 Mar; 19(3):199-224. PubMed ID: 3908456
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Partial maintenance of extra cancellous bone mass by antiresorptive agents after discontinuation of human parathyroid hormone (1-38) in right hindlimb immobilized rats.
    Ma Y; Jee WS; Chen Y; Gasser J; Ke HZ; Li XJ; Kimmel DB
    J Bone Miner Res; 1995 Nov; 10(11):1726-34. PubMed ID: 8592950
    [TBL] [Abstract][Full Text] [Related]  

  • 44. An evaluation of several biochemical markers for bone formation and resorption in a protocol utilizing cyclical parathyroid hormone and calcitonin therapy for osteoporosis.
    Hodsman AB; Fraher LJ; Ostbye T; Adachi JD; Steer BM
    J Clin Invest; 1993 Mar; 91(3):1138-48. PubMed ID: 8450043
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The clinical physiology of calcium homeostasis, parathyroid hormone an, and calcitonin. I.
    Kleeman CR; Massry SG; Coburn JW
    Calif Med; 1971 Mar; 114(3):16-43. PubMed ID: 4927147
    [No Abstract]   [Full Text] [Related]  

  • 46. [Hormones and osteoporosis update. Mechanisms of anabolic and catabolic effects of PTH on bone].
    Kobayashi T
    Clin Calcium; 2009 Jul; 19(7):911-8. PubMed ID: 19567985
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Calcitonin: nature, secretion mechanisms, therapeutic possibilities].
    Franchimont P; Heynen G; Reginster M; Denis F
    Brux Med; 1973 Dec; 53(12):719-27. PubMed ID: 4360270
    [No Abstract]   [Full Text] [Related]  

  • 48. Local communication on and within bone controls bone remodeling.
    Henriksen K; Neutzsky-Wulff AV; Bonewald LF; Karsdal MA
    Bone; 2009 Jun; 44(6):1026-33. PubMed ID: 19345750
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Alcohol, osteoporosis, and bone regulating hormones.
    Sampson HW
    Alcohol Clin Exp Res; 1997 May; 21(3):400-3. PubMed ID: 9161597
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Symposium: interrelations among hormones. 2. Study of thyrocalcitonin and parathormone on the metabolic action of the bone].
    Abe M
    Nihon Naibunpi Gakkai Zasshi; 1970 Feb; 45():Suppl:32. PubMed ID: 5462203
    [No Abstract]   [Full Text] [Related]  

  • 51. [Hormones and osteoporosis].
    Shiraliev OK; Mamedov TF; Gagieva ZhI
    Probl Endokrinol (Mosk); 1994; 40(3):49-52. PubMed ID: 8073006
    [No Abstract]   [Full Text] [Related]  

  • 52. The genetic transformation of bone biology.
    Karsenty G
    Genes Dev; 1999 Dec; 13(23):3037-51. PubMed ID: 10601030
    [No Abstract]   [Full Text] [Related]  

  • 53. [Protein and polypeptide growth factors--parathyroid hormone and calcitonin].
    Ikeda K; Matsumoto T; Ogata E
    Nihon Rinsho; 1986 Jan; 44(1):100-7. PubMed ID: 3514984
    [No Abstract]   [Full Text] [Related]  

  • 54. New insights in bone biology: unmasking skeletal effects of the extracellular calcium-sensing receptor.
    Brown EM; Lian JB
    Sci Signal; 2008 Sep; 1(35):pe40. PubMed ID: 18765829
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Bone remodeling].
    Noda M; Tsuji K; Ishijima M; Usui M; Takamoto M; Kashimada K; Nitou A
    Nihon Rinsho; 2002 Mar; 60 Suppl 3():34-9. PubMed ID: 11979927
    [No Abstract]   [Full Text] [Related]  

  • 56. Voyages of discovery.
    Allgrove J
    Endocr Dev; 2009; 16():1-7. PubMed ID: 19494657
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Physiology of bone--its status quo and view].
    Yamaguchi J; Fujimoto M
    Nihon Seirigaku Zasshi; 1992; 54(4):121-57. PubMed ID: 1322984
    [No Abstract]   [Full Text] [Related]  

  • 58. The roles of the sympathetic nervous system in osteoporotic diseases: A review of experimental and clinical studies.
    He JY; Jiang LS; Dai LY
    Ageing Res Rev; 2011 Apr; 10(2):253-63. PubMed ID: 21262391
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Osteoporosis from the point of view of the clinical endocrinologist.
    Szũcs J
    Agents Actions; 1994 Mar; 41(1-2):80-3. PubMed ID: 8079825
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Involvement of bone in systemic endocrine regulation.
    Zofkova I
    Physiol Res; 2018 Nov; 67(5):669-677. PubMed ID: 30044111
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.